PRIVIA HEALTH GROUP INC (PRVA) Stock Fundamental Analysis

NASDAQ:PRVA • US74276R1023

24.91 USD
+2.26 (+9.98%)
At close: Feb 26, 2026
24.91 USD
0 (0%)
After Hours: 2/26/2026, 8:00:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

Taking everything into account, PRVA scores 4 out of 10 in our fundamental rating. PRVA was compared to 101 industry peers in the Health Care Providers & Services industry. While PRVA has a great health rating, there are worries on its profitability. PRVA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • PRVA had positive earnings in the past year.
  • PRVA had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: PRVA reported negative net income in multiple years.
  • In the past 5 years PRVA always reported a positive cash flow from operatings.
PRVA Yearly Net Income VS EBIT VS OCF VS FCFPRVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

  • PRVA has a Return On Assets (1.34%) which is comparable to the rest of the industry.
  • PRVA's Return On Equity of 2.56% is in line compared to the rest of the industry. PRVA outperforms 56.44% of its industry peers.
  • With a Return On Invested Capital value of 2.45%, PRVA perfoms like the industry average, outperforming 45.54% of the companies in the same industry.
Industry RankSector Rank
ROA 1.34%
ROE 2.56%
ROIC 2.45%
ROA(3y)0.83%
ROA(5y)-3.09%
ROE(3y)1.55%
ROE(5y)-3.63%
ROIC(3y)N/A
ROIC(5y)N/A
PRVA Yearly ROA, ROE, ROICPRVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

  • PRVA has a Profit Margin of 0.89%. This is comparable to the rest of the industry: PRVA outperforms 53.47% of its industry peers.
  • PRVA's Profit Margin has declined in the last couple of years.
  • With a Operating Margin value of 1.38%, PRVA perfoms like the industry average, outperforming 43.56% of the companies in the same industry.
  • PRVA's Operating Margin has declined in the last couple of years.
  • PRVA has a Gross Margin of 10.17%. This is in the lower half of the industry: PRVA underperforms 74.26% of its industry peers.
  • In the last couple of years the Gross Margin of PRVA has grown nicely.
Industry RankSector Rank
OM 1.38%
PM (TTM) 0.89%
GM 10.17%
OM growth 3YN/A
OM growth 5Y-13.74%
PM growth 3YN/A
PM growth 5Y-4.5%
GM growth 3Y15.6%
GM growth 5Y3.18%
PRVA Yearly Profit, Operating, Gross MarginsPRVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PRVA is destroying value.
  • Compared to 1 year ago, PRVA has more shares outstanding
  • Compared to 5 years ago, PRVA has more shares outstanding
  • PRVA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PRVA Yearly Shares OutstandingPRVA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
PRVA Yearly Total Debt VS Total AssetsPRVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • An Altman-Z score of 4.36 indicates that PRVA is not in any danger for bankruptcy at the moment.
  • PRVA's Altman-Z score of 4.36 is fine compared to the rest of the industry. PRVA outperforms 78.22% of its industry peers.
  • There is no outstanding debt for PRVA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.36
ROIC/WACC0.28
WACC8.69%
PRVA Yearly LT Debt VS Equity VS FCFPRVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 1.67 indicates that PRVA should not have too much problems paying its short term obligations.
  • PRVA has a better Current ratio (1.67) than 66.34% of its industry peers.
  • A Quick Ratio of 1.67 indicates that PRVA should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.67, PRVA is in the better half of the industry, outperforming 71.29% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.67
Quick Ratio 1.67
PRVA Yearly Current Assets VS Current LiabilitesPRVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • PRVA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.00%, which is quite impressive.
  • Measured over the past 5 years, PRVA shows a small growth in Earnings Per Share. The EPS has been growing by 7.43% on average per year.
  • PRVA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 19.01%.
  • Measured over the past years, PRVA shows a quite strong growth in Revenue. The Revenue has been growing by 17.17% on average per year.
EPS 1Y (TTM)30%
EPS 3YN/A
EPS 5Y7.43%
EPS Q2Q%66.67%
Revenue 1Y (TTM)19.01%
Revenue growth 3Y21.58%
Revenue growth 5Y17.17%
Sales Q2Q%27.1%

3.2 Future

  • Based on estimates for the next years, PRVA will show a very strong growth in Earnings Per Share. The EPS will grow by 59.93% on average per year.
  • The Revenue is expected to grow by 2.73% on average over the next years.
EPS Next Y22%
EPS Next 2Y71.06%
EPS Next 3Y59.93%
EPS Next 5YN/A
Revenue Next Year-27.71%
Revenue Next 2Y-9.42%
Revenue Next 3Y-3.6%
Revenue Next 5Y2.73%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PRVA Yearly Revenue VS EstimatesPRVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B
PRVA Yearly EPS VS EstimatesPRVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 191.62, PRVA can be considered very expensive at the moment.
  • PRVA's Price/Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Earnings ratio of 27.21, PRVA is valued quite expensively.
  • PRVA is valuated quite expensively with a Price/Forward Earnings ratio of 77.39.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of PRVA is on the same level as its industry peers.
  • The average S&P500 Price/Forward Earnings ratio is at 28.13. PRVA is valued rather expensively when compared to this.
Industry RankSector Rank
PE 191.62
Fwd PE 77.39
PRVA Price Earnings VS Forward Price EarningsPRVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, PRVA is valued a bit more expensive than 65.35% of the companies in the same industry.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as PRVA.
Industry RankSector Rank
P/FCF 27.68
EV/EBITDA 62.88
PRVA Per share dataPRVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • PRVA's earnings are expected to grow with 59.93% in the coming years. This may justify a more expensive valuation.
PEG (NY)8.71
PEG (5Y)25.77
EPS Next 2Y71.06%
EPS Next 3Y59.93%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • PRVA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PRIVIA HEALTH GROUP INC

NASDAQ:PRVA (2/26/2026, 8:00:00 PM)

After market: 24.91 0 (0%)

24.91

+2.26 (+9.98%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-06
Earnings (Next)02-26
Inst Owners98.68%
Inst Owner Change0.49%
Ins Owners1.85%
Ins Owner Change0%
Market Cap3.06B
Revenue(TTM)2.04B
Net Income(TTM)18.17M
Analysts84.29
Price Target32.15 (29.06%)
Short Float %2.31%
Short Ratio3.8
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-34.97%
Min EPS beat(2)-60.96%
Max EPS beat(2)-8.97%
EPS beat(4)0
Avg EPS beat(4)-37.14%
Min EPS beat(4)-60.96%
Max EPS beat(4)-8.97%
EPS beat(8)0
Avg EPS beat(8)-42.01%
EPS beat(12)3
Avg EPS beat(12)40.52%
EPS beat(16)6
Avg EPS beat(16)56.54%
Revenue beat(2)2
Avg Revenue beat(2)11.82%
Min Revenue beat(2)5.73%
Max Revenue beat(2)17.91%
Revenue beat(4)4
Avg Revenue beat(4)8.08%
Min Revenue beat(4)0.75%
Max Revenue beat(4)17.91%
Revenue beat(8)8
Avg Revenue beat(8)5.39%
Revenue beat(12)10
Avg Revenue beat(12)0.33%
Revenue beat(16)10
Avg Revenue beat(16)-9.08%
PT rev (1m)-0.08%
PT rev (3m)-0.1%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-39.01%
EPS NY rev (1m)0%
EPS NY rev (3m)-20.77%
Revenue NQ rev (1m)-7.75%
Revenue NQ rev (3m)-29.23%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-37.44%
Valuation
Industry RankSector Rank
PE 191.62
Fwd PE 77.39
P/S 1.5
P/FCF 27.68
P/OCF 27.68
P/B 4.32
P/tB 8.3
EV/EBITDA 62.88
EPS(TTM)0.13
EY0.52%
EPS(NY)0.32
Fwd EY1.29%
FCF(TTM)0.9
FCFY3.61%
OCF(TTM)0.9
OCFY3.61%
SpS16.61
BVpS5.77
TBVpS3
PEG (NY)8.71
PEG (5Y)25.77
Graham Number4.11
Profitability
Industry RankSector Rank
ROA 1.34%
ROE 2.56%
ROCE 3.67%
ROIC 2.45%
ROICexc 5.77%
ROICexgc N/A
OM 1.38%
PM (TTM) 0.89%
GM 10.17%
FCFM 5.42%
ROA(3y)0.83%
ROA(5y)-3.09%
ROE(3y)1.55%
ROE(5y)-3.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5Y-10.22%
OM growth 3YN/A
OM growth 5Y-13.74%
PM growth 3YN/A
PM growth 5Y-4.5%
GM growth 3Y15.6%
GM growth 5Y3.18%
F-Score7
Asset Turnover1.51
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 112.37
Cash Conversion 296.89%
Profit Quality 609.36%
Current Ratio 1.67
Quick Ratio 1.67
Altman-Z 4.36
F-Score7
WACC8.69%
ROIC/WACC0.28
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30%
EPS 3YN/A
EPS 5Y7.43%
EPS Q2Q%66.67%
EPS Next Y22%
EPS Next 2Y71.06%
EPS Next 3Y59.93%
EPS Next 5YN/A
Revenue 1Y (TTM)19.01%
Revenue growth 3Y21.58%
Revenue growth 5Y17.17%
Sales Q2Q%27.1%
Revenue Next Year-27.71%
Revenue Next 2Y-9.42%
Revenue Next 3Y-3.6%
Revenue Next 5Y2.73%
EBIT growth 1Y114.42%
EBIT growth 3YN/A
EBIT growth 5Y1.07%
EBIT Next Year573.42%
EBIT Next 3Y111.21%
EBIT Next 5Y64.24%
FCF growth 1Y142.02%
FCF growth 3Y26.09%
FCF growth 5Y42.42%
OCF growth 1Y141.5%
OCF growth 3Y25.67%
OCF growth 5Y35.01%

PRIVIA HEALTH GROUP INC / PRVA FAQ

What is the fundamental rating for PRVA stock?

ChartMill assigns a fundamental rating of 4 / 10 to PRVA.


Can you provide the valuation status for PRIVIA HEALTH GROUP INC?

ChartMill assigns a valuation rating of 2 / 10 to PRIVIA HEALTH GROUP INC (PRVA). This can be considered as Overvalued.


Can you provide the profitability details for PRIVIA HEALTH GROUP INC?

PRIVIA HEALTH GROUP INC (PRVA) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for PRVA stock?

The Price/Earnings (PE) ratio for PRIVIA HEALTH GROUP INC (PRVA) is 191.62 and the Price/Book (PB) ratio is 4.32.


Can you provide the financial health for PRVA stock?

The financial health rating of PRIVIA HEALTH GROUP INC (PRVA) is 7 / 10.